Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Sequent Extended Study

NCT: NCT05788432 · ACTIVE_NOT_RECRUITING

NCT IDNCT05788432
StatusACTIVE_NOT_RECRUITING
Start Date2023-03-28
Completion2026-12-01
SponsorFundación EPIC (OTHER)
First posted
Last updated

Brief Summary

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Sequent Please Neo to meet EU Medical Device regulation (MDR) requirements in all the consecutive patients treated with Sequent Please Neo.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑